-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
SAB Biotherapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2021 to Q2 2024.
- SAB Biotherapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $93.1K, a 23.6% increase year-over-year.
- SAB Biotherapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $317K, a 2.75% decline year-over-year.
- SAB Biotherapeutics, Inc. annual Interest Expense for 2023 was $315K, a 4.54% increase from 2022.
- SAB Biotherapeutics, Inc. annual Interest Expense for 2022 was $302K, a 2.42% increase from 2021.
- SAB Biotherapeutics, Inc. annual Interest Expense for 2021 was $294K, a 37.2% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)